Patents by Inventor Kimberly Marlen

Kimberly Marlen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
    Publication number: 20080248010
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Application
    Filed: March 17, 2008
    Publication date: October 9, 2008
    Applicant: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
    Patent number: 7344844
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: March 18, 2008
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
    Publication number: 20060252100
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Application
    Filed: July 17, 2006
    Publication date: November 9, 2006
    Applicant: Metabolex, Inc.
    Inventors: Jeffrey Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
    Patent number: 7109021
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: September 19, 2006
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
    Publication number: 20050233347
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Application
    Filed: November 3, 2004
    Publication date: October 20, 2005
    Applicant: METABOLEX, INC.
    Inventors: Jeffrey Johnson, Yun-Ping Zhou, Kimberly Marlen
  • Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
    Patent number: RE40624
    Abstract: The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: January 20, 2009
    Assignee: Metabolex, Inc.
    Inventors: Jeffrey D. Johnson, Yun-Ping Zhou, Kimberly Marlen